Results
1 -
10 of
61Pharmacokinetics of the dopamine partial agonist, terguride, in the rat and rhesus monkey, European Journal of Drug Metabolism and Pharmacokinetics Comparative Effects of Bromocriptine and the Other Dopamine Agonists, Gynecology and Obstetrics The Dopamine Hypothesis of Schizophrenia 20 Years Later, Search for the Causes of Schizophrenia Behandlungsergebnisse mit pr??synaptischen und postsynaptischen Dopamin-Agonisten bei Minussymptomatik, Fortschritte in der Diagnostik und Therapie schizophrener Minussymptomatik Terguride in Parkinsonism a multicenter trial, European archives of psychiatry and neurological sciences Effect of terguride on prolactin levels in normal, puerperal and hyperprolactinaemic women, European Journal of Clinical Pharmacology Pharmacokinetics and pharmacodynamics in man of the dopamine antagonist ergot derivative, bromerguride, European Journal of Clinical Pharmacology Behavioural profile of partial D2 dopamine receptor agonists, Psychopharmacology Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on the prolactin suppression induced by a series of full and partial dopamine D2 receptor agonists in male rats, Naunyn-Schmiedeberg's Archives of Pharmacology Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors, Naunyn-Schmiedeberg's Archives of Pharmacology